Results 51 to 60 of about 6,330 (191)
Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone [PDF]
First detected in Enterobacteriaceae isolates in Turkey, the OXA-48 carbapenemase has gradually disseminated in the wider Mediterranean area and Europe. Despite reports from other European regions, until now no such isolates have been detected in Greece.
Voulgari, E. +7 more
openaire +3 more sources
Introduction: Tigecycline is a unique class of semi-synthetic glycylcyclines developed to treat infections caused by multidrug-resistant Klebsiella pneumoniae. In the past decades, eight tigecycline-resistant Acinetobacter baumannii isolates have been identified in Tehran and no Klebsiella pneumoniae has been reported.
Rezvan Goodarzi +4 more
openaire +4 more sources
Emergence of Hypervirulent ST11-K64 Klebsiella pneumoniae Poses a Serious Clinical Threat in Older Patients [PDF]
The carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) poses a severe therapeutic challenge to global public health, and research on CR-hvKP in older patients remain limited. In this study, we aimed to investigate the clinical and molecular characteristics and risk factors of CR-hvKP infections in older patients.
Tian Wei +9 more
openaire +3 more sources
Background: Multidrug-resistant bacteria, especially those with high virulence, are an emerging problem in clinical settings. Methods: We conducted a multicentre epidemiological and comparative genomic analysis on the evolution, virulence and ...
Timothy Kudinha (647162) +6 more
core +1 more source
Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing [PDF]
An outbreak of carbapenem-resistant Klebsiella pneumoniae strains emerged at a hospital, and was tracked in order to understand the spread of these infectious pathogens. A total of 66 K. pneumoniae strains were collected from sterile samples in 2012. The MICs of 20 antimicrobial agents were determined for all strains.
Jiang, Y. +5 more
openaire +2 more sources
Yajie Zhao,1,2 Siqin Zhang,1 Renchi Fang,1 Qing Wu,1 Jiahui Li,1 Yizhi Zhang,1 Andrea Rocker,3 Jianming Cao,2 Trevor Lithgow,3 Tieli Zhou1 1Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People ...
Zhao Y +9 more
doaj
Qin Ni,1,2,* Xingwei Yao,3,* Jinhui Li,2,* Jinghan Ma,3,* Kaiying Wang,2 Xiong Liu,2 Peihan Li,2 Lang Yang,2 Peng Li,2 Shenlong Li1,2 1Epidemiology, Zhengzhou University, Zhengzhou, People’s Republic of China; 2Biosafety, Chinese PLA ...
Ni Q +9 more
doaj
Treatment strategies of infection by carbapenem-resistant Klebsiella pneumoniae (CRKP) are limited. Fosfomycin, a broad-spectrum antibiotic, has attracted renewed interest in combination therapy to fight K. pneumoniae infections.
Yingying Hao +9 more
doaj +1 more source
Uncovering the gut microbiota as a reservoir of ST11 hypervirulent KPC-2-producing Klebsiella pneumoniaeUncovering the gut microbiota as a reservoir of ST11 hypervirulent KPC-2-producing Klebsiella pneumoniae [PDF]
Abstract Background: The emergence and spread of ST11 carbapenem-resistant, hypervirulent K. pneumonia (ST11-CR-HvKP) in China generated great concern from the public health community. The identification of ST11-CR-HvKP strain is expected to become a serious public health issue in China, considering the carbapenem resistance and virulence had ...
Beiwen Zheng +11 more
openaire +1 more source
ObjectivesCarbapenem-resistant Klebsiella pneumoniae (CRKP) have been extensively disseminated worldwide, resulting in increased mortality. We performed a retrospective analysis of the epidemiology and risk factors for the outcome of CRKP infection in a ...
Jun Cheng +3 more
doaj +1 more source

